Myriad Genetics Inc (MYGN) Reports 11% Revenue Growth in Q4 and Full-Year 2023
Company Raises 2024 Revenue Guidance and Delivers Positive Adjusted EPS in Q4
Source: yahoo.com
Stay updated with breaking news from Foresight Universal Plus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Company Raises 2024 Revenue Guidance and Delivers Positive Adjusted EPS in Q4
Matt Scalo: Good afternoon and welcome to Myriad Genetics Third Quarter 2023 Earnings Call. During the call, we will review the financial results we released today.